Fosun Pharma Industrial Acquires Additional 334.5 Million Shares of SISRAM MED at HK$3.34 Each

Stock News

Apr 13

On April 8, Fosun Pharma Industrial Pte. Ltd. purchased approximately 334.5 million shares of SISRAM MED (01696) at a price of HK$3.34 per share. The total consideration for the transaction amounted to roughly HK$1.117 billion. Following this acquisition, Fosun Pharma Industrial's total shareholding in the company increased to approximately 334 million shares, representing a 71.42% stake.

In related developments on April 8, 2026, Ample Up Limited and Chindex Medical Limited entered into separate share transfer agreements with Fosun Pharma Industrial Pte. Ltd. Under these agreements, Ample Up agreed to transfer its entire holding of 207,186,160 shares of SISRAM MED, while Chindex Medical agreed to transfer its entire holding of 127,318,640 shares to Fosun Pharma Industrial. Further details are available in the company's announcement dated April 8, 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1178165658"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1178165658\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1178165658?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-13 20:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1178165658","market":"us","top_or_hot":-1,"title":"Fosun Pharma Industrial Acquires Additional 334.5 Million Shares of SISRAM MED at HK$3.34 Each","media":"Stock News","content":"<p>On April 8, Fosun Pharma Industrial Pte. Ltd. purchased approximately 334.5 million shares of SISRAM MED (01696) at a price of HK$3.34 per share. The total consideration for the transaction amounted to roughly HK$1.117 billion. Following this acquisition, Fosun Pharma Industrial's total shareholding in the company increased to approximately 334 million shares, representing a 71.42% stake.</p>\n<p>In related developments on April 8, 2026, Ample Up Limited and Chindex Medical Limited entered into separate share transfer agreements with Fosun Pharma Industrial Pte. Ltd. Under these agreements, Ample Up agreed to transfer its entire holding of 207,186,160 shares of SISRAM MED, while Chindex Medical agreed to transfer its entire holding of 127,318,640 shares to Fosun Pharma Industrial. Further details are available in the company's announcement dated April 8, 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fosun Pharma Industrial Acquires Additional 334.5 Million Shares of SISRAM MED at HK$3.34 Each</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFosun Pharma Industrial Acquires Additional 334.5 Million Shares of SISRAM MED at HK$3.34 Each\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-04-13 20:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On April 8, Fosun Pharma Industrial Pte. Ltd. purchased approximately 334.5 million shares of SISRAM MED (01696) at a price of HK$3.34 per share. The total consideration for the transaction amounted to roughly HK$1.117 billion. Following this acquisition, Fosun Pharma Industrial's total shareholding in the company increased to approximately 334 million shares, representing a 71.42% stake.</p>\n<p>In related developments on April 8, 2026, Ample Up Limited and Chindex Medical Limited entered into separate share transfer agreements with Fosun Pharma Industrial Pte. Ltd. Under these agreements, Ample Up agreed to transfer its entire holding of 207,186,160 shares of SISRAM MED, while Chindex Medical agreed to transfer its entire holding of 127,318,640 shares to Fosun Pharma Industrial. Further details are available in the company's announcement dated April 8, 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1593","symbol_name":"医美概念股","start_time":0,"source_url":"","article_id":"1178165658","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1178165658","pubTimestamp":1776084985,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"On April 8, Fosun Pharma Industrial Pte. Ltd. purchased approximately 334.5 million shares of SISRAM MED (01696) at a price of HK$3.34 per share. The total consideration for the transaction amounted...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1593":"医美概念股","01696":"复锐医疗科技","EWH":"香港ETF-iShares MSCI","BK1585":"昨日强势股","BK1100":"医疗保健设备"},"translate_title":"复星医药产业以每股3.34港元增购Sisram Med 3.345亿股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EWH":1,"01696":1},"content_text":"On April 8, Fosun Pharma Industrial Pte. Ltd. purchased approximately 334.5 million shares of SISRAM MED (01696) at a price of HK$3.34 per share. The total consideration for the transaction amounted to roughly HK$1.117 billion. Following this acquisition, Fosun Pharma Industrial's total shareholding in the company increased to approximately 334 million shares, representing a 71.42% stake.\nIn related developments on April 8, 2026, Ample Up Limited and Chindex Medical Limited entered into separate share transfer agreements with Fosun Pharma Industrial Pte. Ltd. Under these agreements, Ample Up agreed to transfer its entire holding of 207,186,160 shares of SISRAM MED, while Chindex Medical agreed to transfer its entire holding of 127,318,640 shares to Fosun Pharma Industrial. Further details are available in the company's announcement dated April 8, 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}